SingleStrand Biotech is a cutting-edge biotechnology company developing next-generation synthetic oligonucleotide (ODN) therapies to modulate the immune system and promote tissue regeneration. Focused on chronic inflammatory diseases such as Crohn’s Disease, our solution aims to deliver long-lasting effects with high effectiveness rates than current treatments.